International Journal of Diabetes in Developing Countries-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=589243, encodeId=48de58924351, content=同问 2020-04-06 00:00:00 发表: 需要审稿费吗？版面费多少啊, beContent= 2020-04-06 00:00:00 发表: 需要审稿费吗？版面费多少啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e962514599, createdName=124c7de6m42(暂无昵称), createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195265, encodeId=53241195265bb, content=审稿速度:12.0 | 投稿命中率:95.0 偏重的研究方向：糖尿病 经验分享：投稿十一个月接受，只有主编一个改题目的意见。<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=8, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220211/7bbc7a9c7909461b905181b02834d6ae/5c44d6893d014e0ab6471bf9bbcf7de4.jpg, createdBy=0e8a2303171, createdName=LICKSHIE, createdTime=Sun Feb 20 08:19:57 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123931, encodeId=85b5212393135, content=请问这个期刊全部花多少钱？超页一页多少钱？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d788456489, createdName=ms5000001440020074, createdTime=Wed Apr 05 18:47:36 CST 2023, time=2023-04-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1238914, encodeId=62ec123891429, content=请问，有人知道这个杂志的copyright transfer form吗？在网页上找了很久都没有找到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9041303895, createdName=wanghuanjun205, createdTime=Mon Aug 15 23:16:07 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220554, encodeId=4d1c12205548a, content=审稿速度:12.0 偏重的研究方向：糖尿病 经验分享：2021.5.23投出 2022.3.7收到审稿意见 2个审稿人都给出了意见改完2022.4.17提交本来觉得没什么希望了因为文章只是小修但是对审稿人的问题一一回答了 2022.5.17接收感觉还比较好投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06402159320, createdName=ms9810705352398292, createdTime=Tue May 17 21:54:56 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192284, encodeId=c6b71192284d5, content=偏重的研究方向：糖尿病 经验分享：21.3月投稿 22.2.10收到修改意见 22.2.10 返回修改意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220211/7bbc7a9c7909461b905181b02834d6ae/5c44d6893d014e0ab6471bf9bbcf7de4.jpg, createdBy=0e8a2303171, createdName=LICKSHIE, createdTime=Fri Feb 11 12:28:23 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106875, encodeId=ed7321068e59c, content=投稿时间是不是特别长？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Wed Dec 21 00:08:15 CST 2022, time=2022-12-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2106873, encodeId=713321068e3e2, content=这个是不是挺慢的？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Wed Dec 21 00:00:51 CST 2022, time=2022-12-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1238913, encodeId=5344123891321, content=请问，有人知道这个杂志的copyright transfer form吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9041303895, createdName=wanghuanjun205, createdTime=Mon Aug 15 23:14:50 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209650, encodeId=9a42120965002, content=需要审稿费吗？需要患者知情同意书吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Fri Apr 08 20:22:26 CST 2022, time=2022-04-08, status=1, ipAttribution=)]

2020-04-19 124c7de6m42(暂无昵称)

同问 2020-04-06 00:00:00 发表:
需要审稿费吗？版面费多少啊

2020-04-06 00:00:00 发表: 需要审稿费吗？版面费多少啊

222 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=589243, encodeId=48de58924351, content=同问 2020-04-06 00:00:00 发表: 需要审稿费吗？版面费多少啊, beContent= 2020-04-06 00:00:00 发表: 需要审稿费吗？版面费多少啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e962514599, createdName=124c7de6m42(暂无昵称), createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195265, encodeId=53241195265bb, content=审稿速度:12.0 | 投稿命中率:95.0 偏重的研究方向：糖尿病 经验分享：投稿十一个月接受，只有主编一个改题目的意见。<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=8, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220211/7bbc7a9c7909461b905181b02834d6ae/5c44d6893d014e0ab6471bf9bbcf7de4.jpg, createdBy=0e8a2303171, createdName=LICKSHIE, createdTime=Sun Feb 20 08:19:57 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123931, encodeId=85b5212393135, content=请问这个期刊全部花多少钱？超页一页多少钱？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d788456489, createdName=ms5000001440020074, createdTime=Wed Apr 05 18:47:36 CST 2023, time=2023-04-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1238914, encodeId=62ec123891429, content=请问，有人知道这个杂志的copyright transfer form吗？在网页上找了很久都没有找到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9041303895, createdName=wanghuanjun205, createdTime=Mon Aug 15 23:16:07 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220554, encodeId=4d1c12205548a, content=审稿速度:12.0 偏重的研究方向：糖尿病 经验分享：2021.5.23投出 2022.3.7收到审稿意见 2个审稿人都给出了意见改完2022.4.17提交本来觉得没什么希望了因为文章只是小修但是对审稿人的问题一一回答了 2022.5.17接收感觉还比较好投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06402159320, createdName=ms9810705352398292, createdTime=Tue May 17 21:54:56 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192284, encodeId=c6b71192284d5, content=偏重的研究方向：糖尿病 经验分享：21.3月投稿 22.2.10收到修改意见 22.2.10 返回修改意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220211/7bbc7a9c7909461b905181b02834d6ae/5c44d6893d014e0ab6471bf9bbcf7de4.jpg, createdBy=0e8a2303171, createdName=LICKSHIE, createdTime=Fri Feb 11 12:28:23 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106875, encodeId=ed7321068e59c, content=投稿时间是不是特别长？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Wed Dec 21 00:08:15 CST 2022, time=2022-12-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2106873, encodeId=713321068e3e2, content=这个是不是挺慢的？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Wed Dec 21 00:00:51 CST 2022, time=2022-12-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1238913, encodeId=5344123891321, content=请问，有人知道这个杂志的copyright transfer form吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9041303895, createdName=wanghuanjun205, createdTime=Mon Aug 15 23:14:50 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209650, encodeId=9a42120965002, content=需要审稿费吗？需要患者知情同意书吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Fri Apr 08 20:22:26 CST 2022, time=2022-04-08, status=1, ipAttribution=)]

2022-02-20 LICKSHIE

审稿速度:12.0 | 投稿命中率:95.0
偏重的研究方向：糖尿病
经验分享：投稿十一个月接受，只有主编一个改题目的意见。#期刊论坛#

348 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=589243, encodeId=48de58924351, content=同问 2020-04-06 00:00:00 发表: 需要审稿费吗？版面费多少啊, beContent= 2020-04-06 00:00:00 发表: 需要审稿费吗？版面费多少啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e962514599, createdName=124c7de6m42(暂无昵称), createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195265, encodeId=53241195265bb, content=审稿速度:12.0 | 投稿命中率:95.0 偏重的研究方向：糖尿病 经验分享：投稿十一个月接受，只有主编一个改题目的意见。<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=8, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220211/7bbc7a9c7909461b905181b02834d6ae/5c44d6893d014e0ab6471bf9bbcf7de4.jpg, createdBy=0e8a2303171, createdName=LICKSHIE, createdTime=Sun Feb 20 08:19:57 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123931, encodeId=85b5212393135, content=请问这个期刊全部花多少钱？超页一页多少钱？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d788456489, createdName=ms5000001440020074, createdTime=Wed Apr 05 18:47:36 CST 2023, time=2023-04-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1238914, encodeId=62ec123891429, content=请问，有人知道这个杂志的copyright transfer form吗？在网页上找了很久都没有找到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9041303895, createdName=wanghuanjun205, createdTime=Mon Aug 15 23:16:07 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220554, encodeId=4d1c12205548a, content=审稿速度:12.0 偏重的研究方向：糖尿病 经验分享：2021.5.23投出 2022.3.7收到审稿意见 2个审稿人都给出了意见改完2022.4.17提交本来觉得没什么希望了因为文章只是小修但是对审稿人的问题一一回答了 2022.5.17接收感觉还比较好投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06402159320, createdName=ms9810705352398292, createdTime=Tue May 17 21:54:56 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192284, encodeId=c6b71192284d5, content=偏重的研究方向：糖尿病 经验分享：21.3月投稿 22.2.10收到修改意见 22.2.10 返回修改意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220211/7bbc7a9c7909461b905181b02834d6ae/5c44d6893d014e0ab6471bf9bbcf7de4.jpg, createdBy=0e8a2303171, createdName=LICKSHIE, createdTime=Fri Feb 11 12:28:23 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106875, encodeId=ed7321068e59c, content=投稿时间是不是特别长？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Wed Dec 21 00:08:15 CST 2022, time=2022-12-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2106873, encodeId=713321068e3e2, content=这个是不是挺慢的？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Wed Dec 21 00:00:51 CST 2022, time=2022-12-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1238913, encodeId=5344123891321, content=请问，有人知道这个杂志的copyright transfer form吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9041303895, createdName=wanghuanjun205, createdTime=Mon Aug 15 23:14:50 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209650, encodeId=9a42120965002, content=需要审稿费吗？需要患者知情同意书吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Fri Apr 08 20:22:26 CST 2022, time=2022-04-08, status=1, ipAttribution=)]

2023-04-05 ms5000001440020074 来自广东省

请问这个期刊全部花多少钱？超页一页多少钱？

82 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=589243, encodeId=48de58924351, content=同问 2020-04-06 00:00:00 发表: 需要审稿费吗？版面费多少啊, beContent= 2020-04-06 00:00:00 发表: 需要审稿费吗？版面费多少啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e962514599, createdName=124c7de6m42(暂无昵称), createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195265, encodeId=53241195265bb, content=审稿速度:12.0 | 投稿命中率:95.0 偏重的研究方向：糖尿病 经验分享：投稿十一个月接受，只有主编一个改题目的意见。<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=8, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220211/7bbc7a9c7909461b905181b02834d6ae/5c44d6893d014e0ab6471bf9bbcf7de4.jpg, createdBy=0e8a2303171, createdName=LICKSHIE, createdTime=Sun Feb 20 08:19:57 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123931, encodeId=85b5212393135, content=请问这个期刊全部花多少钱？超页一页多少钱？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d788456489, createdName=ms5000001440020074, createdTime=Wed Apr 05 18:47:36 CST 2023, time=2023-04-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1238914, encodeId=62ec123891429, content=请问，有人知道这个杂志的copyright transfer form吗？在网页上找了很久都没有找到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9041303895, createdName=wanghuanjun205, createdTime=Mon Aug 15 23:16:07 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220554, encodeId=4d1c12205548a, content=审稿速度:12.0 偏重的研究方向：糖尿病 经验分享：2021.5.23投出 2022.3.7收到审稿意见 2个审稿人都给出了意见改完2022.4.17提交本来觉得没什么希望了因为文章只是小修但是对审稿人的问题一一回答了 2022.5.17接收感觉还比较好投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06402159320, createdName=ms9810705352398292, createdTime=Tue May 17 21:54:56 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192284, encodeId=c6b71192284d5, content=偏重的研究方向：糖尿病 经验分享：21.3月投稿 22.2.10收到修改意见 22.2.10 返回修改意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220211/7bbc7a9c7909461b905181b02834d6ae/5c44d6893d014e0ab6471bf9bbcf7de4.jpg, createdBy=0e8a2303171, createdName=LICKSHIE, createdTime=Fri Feb 11 12:28:23 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106875, encodeId=ed7321068e59c, content=投稿时间是不是特别长？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Wed Dec 21 00:08:15 CST 2022, time=2022-12-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2106873, encodeId=713321068e3e2, content=这个是不是挺慢的？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Wed Dec 21 00:00:51 CST 2022, time=2022-12-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1238913, encodeId=5344123891321, content=请问，有人知道这个杂志的copyright transfer form吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9041303895, createdName=wanghuanjun205, createdTime=Mon Aug 15 23:14:50 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209650, encodeId=9a42120965002, content=需要审稿费吗？需要患者知情同意书吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Fri Apr 08 20:22:26 CST 2022, time=2022-04-08, status=1, ipAttribution=)]

2022-08-15 wanghuanjun205

请问，有人知道这个杂志的copyright transfer form吗？在网页上找了很久都没有找到。

87 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=589243, encodeId=48de58924351, content=同问 2020-04-06 00:00:00 发表: 需要审稿费吗？版面费多少啊, beContent= 2020-04-06 00:00:00 发表: 需要审稿费吗？版面费多少啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e962514599, createdName=124c7de6m42(暂无昵称), createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195265, encodeId=53241195265bb, content=审稿速度:12.0 | 投稿命中率:95.0 偏重的研究方向：糖尿病 经验分享：投稿十一个月接受，只有主编一个改题目的意见。<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=8, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220211/7bbc7a9c7909461b905181b02834d6ae/5c44d6893d014e0ab6471bf9bbcf7de4.jpg, createdBy=0e8a2303171, createdName=LICKSHIE, createdTime=Sun Feb 20 08:19:57 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123931, encodeId=85b5212393135, content=请问这个期刊全部花多少钱？超页一页多少钱？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d788456489, createdName=ms5000001440020074, createdTime=Wed Apr 05 18:47:36 CST 2023, time=2023-04-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1238914, encodeId=62ec123891429, content=请问，有人知道这个杂志的copyright transfer form吗？在网页上找了很久都没有找到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9041303895, createdName=wanghuanjun205, createdTime=Mon Aug 15 23:16:07 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220554, encodeId=4d1c12205548a, content=审稿速度:12.0 偏重的研究方向：糖尿病 经验分享：2021.5.23投出 2022.3.7收到审稿意见 2个审稿人都给出了意见改完2022.4.17提交本来觉得没什么希望了因为文章只是小修但是对审稿人的问题一一回答了 2022.5.17接收感觉还比较好投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06402159320, createdName=ms9810705352398292, createdTime=Tue May 17 21:54:56 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192284, encodeId=c6b71192284d5, content=偏重的研究方向：糖尿病 经验分享：21.3月投稿 22.2.10收到修改意见 22.2.10 返回修改意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220211/7bbc7a9c7909461b905181b02834d6ae/5c44d6893d014e0ab6471bf9bbcf7de4.jpg, createdBy=0e8a2303171, createdName=LICKSHIE, createdTime=Fri Feb 11 12:28:23 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106875, encodeId=ed7321068e59c, content=投稿时间是不是特别长？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Wed Dec 21 00:08:15 CST 2022, time=2022-12-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2106873, encodeId=713321068e3e2, content=这个是不是挺慢的？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Wed Dec 21 00:00:51 CST 2022, time=2022-12-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1238913, encodeId=5344123891321, content=请问，有人知道这个杂志的copyright transfer form吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9041303895, createdName=wanghuanjun205, createdTime=Mon Aug 15 23:14:50 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209650, encodeId=9a42120965002, content=需要审稿费吗？需要患者知情同意书吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Fri Apr 08 20:22:26 CST 2022, time=2022-04-08, status=1, ipAttribution=)]

2022-05-17 ms9810705352398292

审稿速度:12.0
偏重的研究方向：糖尿病
经验分享：2021.5.23投出 2022.3.7收到审稿意见 2个审稿人都给出了意见改完2022.4.17提交本来觉得没什么希望了因为文章只是小修但是对审稿人的问题一一回答了 2022.5.17接收感觉还比较好投

92 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=589243, encodeId=48de58924351, content=同问 2020-04-06 00:00:00 发表: 需要审稿费吗？版面费多少啊, beContent= 2020-04-06 00:00:00 发表: 需要审稿费吗？版面费多少啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e962514599, createdName=124c7de6m42(暂无昵称), createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195265, encodeId=53241195265bb, content=审稿速度:12.0 | 投稿命中率:95.0 偏重的研究方向：糖尿病 经验分享：投稿十一个月接受，只有主编一个改题目的意见。<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=8, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220211/7bbc7a9c7909461b905181b02834d6ae/5c44d6893d014e0ab6471bf9bbcf7de4.jpg, createdBy=0e8a2303171, createdName=LICKSHIE, createdTime=Sun Feb 20 08:19:57 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123931, encodeId=85b5212393135, content=请问这个期刊全部花多少钱？超页一页多少钱？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d788456489, createdName=ms5000001440020074, createdTime=Wed Apr 05 18:47:36 CST 2023, time=2023-04-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1238914, encodeId=62ec123891429, content=请问，有人知道这个杂志的copyright transfer form吗？在网页上找了很久都没有找到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9041303895, createdName=wanghuanjun205, createdTime=Mon Aug 15 23:16:07 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220554, encodeId=4d1c12205548a, content=审稿速度:12.0 偏重的研究方向：糖尿病 经验分享：2021.5.23投出 2022.3.7收到审稿意见 2个审稿人都给出了意见改完2022.4.17提交本来觉得没什么希望了因为文章只是小修但是对审稿人的问题一一回答了 2022.5.17接收感觉还比较好投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06402159320, createdName=ms9810705352398292, createdTime=Tue May 17 21:54:56 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192284, encodeId=c6b71192284d5, content=偏重的研究方向：糖尿病 经验分享：21.3月投稿 22.2.10收到修改意见 22.2.10 返回修改意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220211/7bbc7a9c7909461b905181b02834d6ae/5c44d6893d014e0ab6471bf9bbcf7de4.jpg, createdBy=0e8a2303171, createdName=LICKSHIE, createdTime=Fri Feb 11 12:28:23 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106875, encodeId=ed7321068e59c, content=投稿时间是不是特别长？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Wed Dec 21 00:08:15 CST 2022, time=2022-12-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2106873, encodeId=713321068e3e2, content=这个是不是挺慢的？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Wed Dec 21 00:00:51 CST 2022, time=2022-12-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1238913, encodeId=5344123891321, content=请问，有人知道这个杂志的copyright transfer form吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9041303895, createdName=wanghuanjun205, createdTime=Mon Aug 15 23:14:50 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209650, encodeId=9a42120965002, content=需要审稿费吗？需要患者知情同意书吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Fri Apr 08 20:22:26 CST 2022, time=2022-04-08, status=1, ipAttribution=)]

2022-02-11 LICKSHIE

偏重的研究方向：糖尿病
经验分享：21.3月投稿 22.2.10收到修改意见 22.2.10 返回修改意见

185 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=589243, encodeId=48de58924351, content=同问 2020-04-06 00:00:00 发表: 需要审稿费吗？版面费多少啊, beContent= 2020-04-06 00:00:00 发表: 需要审稿费吗？版面费多少啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e962514599, createdName=124c7de6m42(暂无昵称), createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195265, encodeId=53241195265bb, content=审稿速度:12.0 | 投稿命中率:95.0 偏重的研究方向：糖尿病 经验分享：投稿十一个月接受，只有主编一个改题目的意见。<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=8, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220211/7bbc7a9c7909461b905181b02834d6ae/5c44d6893d014e0ab6471bf9bbcf7de4.jpg, createdBy=0e8a2303171, createdName=LICKSHIE, createdTime=Sun Feb 20 08:19:57 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123931, encodeId=85b5212393135, content=请问这个期刊全部花多少钱？超页一页多少钱？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d788456489, createdName=ms5000001440020074, createdTime=Wed Apr 05 18:47:36 CST 2023, time=2023-04-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1238914, encodeId=62ec123891429, content=请问，有人知道这个杂志的copyright transfer form吗？在网页上找了很久都没有找到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9041303895, createdName=wanghuanjun205, createdTime=Mon Aug 15 23:16:07 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220554, encodeId=4d1c12205548a, content=审稿速度:12.0 偏重的研究方向：糖尿病 经验分享：2021.5.23投出 2022.3.7收到审稿意见 2个审稿人都给出了意见改完2022.4.17提交本来觉得没什么希望了因为文章只是小修但是对审稿人的问题一一回答了 2022.5.17接收感觉还比较好投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06402159320, createdName=ms9810705352398292, createdTime=Tue May 17 21:54:56 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192284, encodeId=c6b71192284d5, content=偏重的研究方向：糖尿病 经验分享：21.3月投稿 22.2.10收到修改意见 22.2.10 返回修改意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220211/7bbc7a9c7909461b905181b02834d6ae/5c44d6893d014e0ab6471bf9bbcf7de4.jpg, createdBy=0e8a2303171, createdName=LICKSHIE, createdTime=Fri Feb 11 12:28:23 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106875, encodeId=ed7321068e59c, content=投稿时间是不是特别长？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Wed Dec 21 00:08:15 CST 2022, time=2022-12-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2106873, encodeId=713321068e3e2, content=这个是不是挺慢的？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Wed Dec 21 00:00:51 CST 2022, time=2022-12-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1238913, encodeId=5344123891321, content=请问，有人知道这个杂志的copyright transfer form吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9041303895, createdName=wanghuanjun205, createdTime=Mon Aug 15 23:14:50 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209650, encodeId=9a42120965002, content=需要审稿费吗？需要患者知情同意书吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Fri Apr 08 20:22:26 CST 2022, time=2022-04-08, status=1, ipAttribution=)]

2022-12-21 13007594m29暂无昵称来自河北省

投稿时间是不是特别长？

80 0

[GetPortalCommentsPageByObjectIdResponse(id=589243, encodeId=48de58924351, content=同问 2020-04-06 00:00:00 发表: 需要审稿费吗？版面费多少啊, beContent= 2020-04-06 00:00:00 发表: 需要审稿费吗？版面费多少啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e962514599, createdName=124c7de6m42(暂无昵称), createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195265, encodeId=53241195265bb, content=审稿速度:12.0 | 投稿命中率:95.0 偏重的研究方向：糖尿病 经验分享：投稿十一个月接受，只有主编一个改题目的意见。<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=8, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220211/7bbc7a9c7909461b905181b02834d6ae/5c44d6893d014e0ab6471bf9bbcf7de4.jpg, createdBy=0e8a2303171, createdName=LICKSHIE, createdTime=Sun Feb 20 08:19:57 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123931, encodeId=85b5212393135, content=请问这个期刊全部花多少钱？超页一页多少钱？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d788456489, createdName=ms5000001440020074, createdTime=Wed Apr 05 18:47:36 CST 2023, time=2023-04-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1238914, encodeId=62ec123891429, content=请问，有人知道这个杂志的copyright transfer form吗？在网页上找了很久都没有找到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9041303895, createdName=wanghuanjun205, createdTime=Mon Aug 15 23:16:07 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220554, encodeId=4d1c12205548a, content=审稿速度:12.0 偏重的研究方向：糖尿病 经验分享：2021.5.23投出 2022.3.7收到审稿意见 2个审稿人都给出了意见改完2022.4.17提交本来觉得没什么希望了因为文章只是小修但是对审稿人的问题一一回答了 2022.5.17接收感觉还比较好投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06402159320, createdName=ms9810705352398292, createdTime=Tue May 17 21:54:56 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192284, encodeId=c6b71192284d5, content=偏重的研究方向：糖尿病 经验分享：21.3月投稿 22.2.10收到修改意见 22.2.10 返回修改意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220211/7bbc7a9c7909461b905181b02834d6ae/5c44d6893d014e0ab6471bf9bbcf7de4.jpg, createdBy=0e8a2303171, createdName=LICKSHIE, createdTime=Fri Feb 11 12:28:23 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106875, encodeId=ed7321068e59c, content=投稿时间是不是特别长？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Wed Dec 21 00:08:15 CST 2022, time=2022-12-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2106873, encodeId=713321068e3e2, content=这个是不是挺慢的？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Wed Dec 21 00:00:51 CST 2022, time=2022-12-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1238913, encodeId=5344123891321, content=请问，有人知道这个杂志的copyright transfer form吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9041303895, createdName=wanghuanjun205, createdTime=Mon Aug 15 23:14:50 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209650, encodeId=9a42120965002, content=需要审稿费吗？需要患者知情同意书吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Fri Apr 08 20:22:26 CST 2022, time=2022-04-08, status=1, ipAttribution=)]

2022-12-21 13007594m29暂无昵称来自河北省

这个是不是挺慢的？

77 0

[GetPortalCommentsPageByObjectIdResponse(id=589243, encodeId=48de58924351, content=同问 2020-04-06 00:00:00 发表: 需要审稿费吗？版面费多少啊, beContent= 2020-04-06 00:00:00 发表: 需要审稿费吗？版面费多少啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e962514599, createdName=124c7de6m42(暂无昵称), createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195265, encodeId=53241195265bb, content=审稿速度:12.0 | 投稿命中率:95.0 偏重的研究方向：糖尿病 经验分享：投稿十一个月接受，只有主编一个改题目的意见。<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=8, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220211/7bbc7a9c7909461b905181b02834d6ae/5c44d6893d014e0ab6471bf9bbcf7de4.jpg, createdBy=0e8a2303171, createdName=LICKSHIE, createdTime=Sun Feb 20 08:19:57 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123931, encodeId=85b5212393135, content=请问这个期刊全部花多少钱？超页一页多少钱？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d788456489, createdName=ms5000001440020074, createdTime=Wed Apr 05 18:47:36 CST 2023, time=2023-04-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1238914, encodeId=62ec123891429, content=请问，有人知道这个杂志的copyright transfer form吗？在网页上找了很久都没有找到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9041303895, createdName=wanghuanjun205, createdTime=Mon Aug 15 23:16:07 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220554, encodeId=4d1c12205548a, content=审稿速度:12.0 偏重的研究方向：糖尿病 经验分享：2021.5.23投出 2022.3.7收到审稿意见 2个审稿人都给出了意见改完2022.4.17提交本来觉得没什么希望了因为文章只是小修但是对审稿人的问题一一回答了 2022.5.17接收感觉还比较好投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06402159320, createdName=ms9810705352398292, createdTime=Tue May 17 21:54:56 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192284, encodeId=c6b71192284d5, content=偏重的研究方向：糖尿病 经验分享：21.3月投稿 22.2.10收到修改意见 22.2.10 返回修改意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220211/7bbc7a9c7909461b905181b02834d6ae/5c44d6893d014e0ab6471bf9bbcf7de4.jpg, createdBy=0e8a2303171, createdName=LICKSHIE, createdTime=Fri Feb 11 12:28:23 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106875, encodeId=ed7321068e59c, content=投稿时间是不是特别长？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Wed Dec 21 00:08:15 CST 2022, time=2022-12-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2106873, encodeId=713321068e3e2, content=这个是不是挺慢的？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Wed Dec 21 00:00:51 CST 2022, time=2022-12-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1238913, encodeId=5344123891321, content=请问，有人知道这个杂志的copyright transfer form吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9041303895, createdName=wanghuanjun205, createdTime=Mon Aug 15 23:14:50 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209650, encodeId=9a42120965002, content=需要审稿费吗？需要患者知情同意书吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Fri Apr 08 20:22:26 CST 2022, time=2022-04-08, status=1, ipAttribution=)]

2022-08-15 wanghuanjun205

请问，有人知道这个杂志的copyright transfer form吗？谢谢

0 0

[GetPortalCommentsPageByObjectIdResponse(id=589243, encodeId=48de58924351, content=同问 2020-04-06 00:00:00 发表: 需要审稿费吗？版面费多少啊, beContent= 2020-04-06 00:00:00 发表: 需要审稿费吗？版面费多少啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e962514599, createdName=124c7de6m42(暂无昵称), createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195265, encodeId=53241195265bb, content=审稿速度:12.0 | 投稿命中率:95.0 偏重的研究方向：糖尿病 经验分享：投稿十一个月接受，只有主编一个改题目的意见。<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=8, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220211/7bbc7a9c7909461b905181b02834d6ae/5c44d6893d014e0ab6471bf9bbcf7de4.jpg, createdBy=0e8a2303171, createdName=LICKSHIE, createdTime=Sun Feb 20 08:19:57 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123931, encodeId=85b5212393135, content=请问这个期刊全部花多少钱？超页一页多少钱？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d788456489, createdName=ms5000001440020074, createdTime=Wed Apr 05 18:47:36 CST 2023, time=2023-04-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1238914, encodeId=62ec123891429, content=请问，有人知道这个杂志的copyright transfer form吗？在网页上找了很久都没有找到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9041303895, createdName=wanghuanjun205, createdTime=Mon Aug 15 23:16:07 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220554, encodeId=4d1c12205548a, content=审稿速度:12.0 偏重的研究方向：糖尿病 经验分享：2021.5.23投出 2022.3.7收到审稿意见 2个审稿人都给出了意见改完2022.4.17提交本来觉得没什么希望了因为文章只是小修但是对审稿人的问题一一回答了 2022.5.17接收感觉还比较好投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06402159320, createdName=ms9810705352398292, createdTime=Tue May 17 21:54:56 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192284, encodeId=c6b71192284d5, content=偏重的研究方向：糖尿病 经验分享：21.3月投稿 22.2.10收到修改意见 22.2.10 返回修改意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220211/7bbc7a9c7909461b905181b02834d6ae/5c44d6893d014e0ab6471bf9bbcf7de4.jpg, createdBy=0e8a2303171, createdName=LICKSHIE, createdTime=Fri Feb 11 12:28:23 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106875, encodeId=ed7321068e59c, content=投稿时间是不是特别长？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Wed Dec 21 00:08:15 CST 2022, time=2022-12-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2106873, encodeId=713321068e3e2, content=这个是不是挺慢的？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Wed Dec 21 00:00:51 CST 2022, time=2022-12-21, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1238913, encodeId=5344123891321, content=请问，有人知道这个杂志的copyright transfer form吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9041303895, createdName=wanghuanjun205, createdTime=Mon Aug 15 23:14:50 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209650, encodeId=9a42120965002, content=需要审稿费吗？需要患者知情同意书吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Fri Apr 08 20:22:26 CST 2022, time=2022-04-08, status=1, ipAttribution=)]

2022-04-08 13007594m29暂无昵称

需要审稿费吗？需要患者知情同意书吗？

119 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务